AIDS
- KEMP CG, Pence BW, Velloza J, Concepcion T, et al
Cumulative exposure to depressive symptoms and all-cause mortality among adults
living with HIV in Kenya, Nigeria, Tanzania, and Uganda.
AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003891.
- MIGISHA R, Chen G, Muyindike WR, Aung TN, et al
Regional variation in weight change after the transition to dolutegravir: a
prospective cohort study in Uganda and South Africa.
AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003888.
- HAW NJL, Lesko CR, Ng DK, Lam J, et al
Incidence of non-AIDS defining comorbidities among young adults with
perinatally-acquired HIV in North America, 2000-2019.
AIDS. 2024 Mar 19. doi: 10.1097/QAD.0000000000003892.
- CHOLLI PA, Buchacz KM, Harris NS, Crim SM, et al
Self-rated Health and HIV Outcomes Among Adults with Diagnosed HIV - Medical
Monitoring Project, United States, 2020-21.
AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003890.
- HU FH, Tang XL, Ge MW, Jia YJ, et al
Mortality of children and adolescents co-infected with tuberculosis and HIV: a
systematic review and meta-analysis.
AIDS. 2024 Mar 18. doi: 10.1097/QAD.0000000000003886.
AIDS Res Hum Retroviruses
- LAN C, Zhu B, Hailong Z, Yuting S, et al
Near Full-Length Genome Characterization of two Novel Unique Recombinants
(CRF01_AE/CRF07_BC) in Beijing, China.
AIDS Res Hum Retroviruses. 2024 Mar 22. doi: 10.1089/AID.2023.0149.
- LE BRAZIDEC DL, Cormier K, Almonte A, Napoleon S, et al
Pre-Exposure Prophylaxis Care Cascade Among Men Who Have Sex with Men Engaging in
Partner Notification Services at a Sexually Transmitted Infections Clinic.
AIDS Res Hum Retroviruses. 2024 Mar 18. doi: 10.1089/aid.2023.0097.
Am J Med
- ALI K, Wiemer L, Ali AA, Quan A, et al
Gastrointestinal Bleeding Related to Visceral Kaposi Sarcoma.
Am J Med. 2024 Mar 16:S0002-9343(24)00171-2. doi: 10.1016/j.amjmed.2024.
Clin Infect Dis
- KRISHNAN S, Chaisson RE
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
Clin Infect Dis. 2024;78:514-517.
- BOODMAN C, Gupta N, Nelson CA, van Griensven J, et al
Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
Clin Infect Dis. 2024;78:554-561.
- KENYON C
We should not downplay the risks that doxycycline PEP will select for AMR.
Clin Infect Dis. 2024 Mar 19:ciae139. doi: 10.1093.
- HAZRA A, Celum C, Luetkemeyer AF, Molina JM, et al
Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its
well-Informed implementation.
Clin Infect Dis. 2024 Mar 19:ciae152. doi: 10.1093.
- NGUYEN Q, Wooten D, Lee D, Moreno M, et al
GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV.
Clin Infect Dis. 2024 Mar 19:ciae151. doi: 10.1093.
- VALIN N, Lambert-Niclot S, Torres E, Meynard JL, et al
A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on
Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine.
Clin Infect Dis. 2024 Mar 21:ciad757. doi: 10.1093.
- VANBAELEN T, Tsoumanis A, Kenyon C
Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts
and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
Clin Infect Dis. 2024;78:803-805.
HIV Med
- SOCIAS ME, Cui Z, Le Foll B, Lei J, et al
Sexually transmitted and blood-borne infection risk reduction with methadone and
buprenorphine/naloxone among people with prescription-type opioid use disorder:
Findings from a Canadian pragmatic randomized trial.
HIV Med. 2024 Mar 20. doi: 10.1111/hiv.13636.
- ZOU S, Chen Z, Tan Y, Tan M, et al
Microbiomes detected by cerebrospinal fluid metagenomic next-generation
sequencing among patients with and without HIV with suspected central nervous
system infection.
HIV Med. 2024 Mar 21. doi: 10.1111/hiv.13634.
- JACOBS TG, Okemo D, Ssebagereka A, Mwehonge K, et al
Availability and stock-outs of paediatric antiretroviral treatment formulations
at health facilities in Kenya and Uganda.
HIV Med. 2024 Mar 18. doi: 10.1111/hiv.13635.
- DOU Y, Lu R, Su L, Lan K, et al
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using
a rifampicin-based regimen: A retrospective observational case series.
HIV Med. 2024 Mar 17. doi: 10.1111/hiv.13632.
J Acquir Immune Defic Syndr
- ERENRICH RK, Braun RA, Torres-Mendoza DM, Stevenson OL, et al
Effectiveness of PrEPTECH: Findings From a 180-Day Randomized Controlled Trial of
a Pre-Exposure Prophylaxis Telehealth Intervention.
J Acquir Immune Defic Syndr. 2024;95:463-469.
J Clin Oncol
- MCGEE-AVILA JK, Suneja G, Engels EA, Rositch AF, et al
Cancer Treatment Disparities in People With HIV in the United States, 2001-2019.
J Clin Oncol. 2024 Mar 21:JCO2302366. doi: 10.1200/JCO.23.02366.
J Infect Dis
- ZEEB M, Frischknecht P, Huber M, Schenkel CD, et al
Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
J Infect Dis. 2024 Mar 20:jiae149. doi: 10.1093.
J Med Virol
- WANG Z
Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase
inhibitors with improved resistance profile.
J Med Virol. 2024;96:e29553.
- TRUNFIO M, Tang B, Okwuegbuna O, Iudicello JE, et al
Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification
of CSF controllers.
J Med Virol. 2024;96:e29550.
J Pediatr
- BARRIOS-TASCON A, Strehlau R, Patel F, Burke M, et al
Growth Trajectories over the First Year of Life among Early-treated Infants with
HIV and Infants Who Are HIV-exposed Uninfected.
J Pediatr. 2024 Mar 18:114018. doi: 10.1016/j.jpeds.2024.114018.
J Virol
- VON MALTITZ P, Wettstein L, Weil T, Schommers P, et al
Semen enhances transmitted/founder HIV-1 infection and only marginally reduces
antiviral activity of broadly neutralizing antibodies.
J Virol. 2024 Mar 19:e0119023. doi: 10.1128/jvi.01190.
- TWENTYMAN J, Emerman M, Ohainle M
Capsid-dependent lentiviral restrictions.
J Virol. 2024 Mar 18:e0030824. doi: 10.1128/jvi.00308.
JAMA
- SHETH AN, Momplaisir F, Dumond JB
Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for
Cisgender Women.
JAMA. 2024;331:912-914.
Lancet
- WATTS G
Andrew Kerkhoff: award-winning TB and HIV physician-scientist.
Lancet. 2024 Mar 15:S0140-6736(24)00539-7. doi: 10.1016/S0140-6736(24)00539.
Lancet Infect Dis
- STUCK L, Klinkenberg E, Abdelgadir Ali N, Basheir Abukaraig EA, et al
Prevalence of subclinical pulmonary tuberculosis in adults in community settings:
an individual participant data meta-analysis.
Lancet Infect Dis. 2024 Mar 12:S1473-3099(24)00011.
Lancet Neurol
-
Global, regional, and national burden of disorders affecting the nervous system,
1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet Neurol. 2024;23:344-381.
MMWR Morb Mortal Wkly Rep
- AJIBOYE AS, O'Connor S, Smith JP, Ahmedov S, et al
Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for
AIDS Relief, 36 Countries, 2016-2023.
MMWR Morb Mortal Wkly Rep. 2024;73:233-238.
Neurol Clin Pract
- MBONDE AA, Chang J, Musubire AK, Okello S, et al
HIV Infection and 90-Day Stroke Outcomes in Uganda: A Prospective Observational
Cohort Study.
Neurol Clin Pract. 2023;13:e200198.
PLoS Med
- EMANI S, Alves K, Alves LC, da Silva DA, et al
Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model
study using national program data.
PLoS Med. 2024;21:e1004361.
- MOODIE Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, et al
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus
bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy
adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med. 2024;21:e1004360.
- BRAZIER E, Tymejczyk O, Wools-Kaloustian K, Jiamsakul A, et al
Long-term HIV care outcomes under universal HIV treatment guidelines: A
retrospective cohort study in 25 countries.
PLoS Med. 2024;21:e1004367.
PLoS One
- TUMWEGAMIRE A, Fatch R, Emenyonu NI, Lodi S, et al
Association between smoking and lack of HIV virological suppression in a
cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
PLoS One. 2024;19:e0300508.
- SAGNIA B, Mbakop Ghomsi F, Moudourou S, Gutierez A, et al
Accurate and reproducible enumeration of CD4 T cell counts and Hemoglobin levels
using a point of care system: Comparison with conventional laboratory based
testing systems in a clinical reference laboratory in Cameroon.
PLoS One. 2024;19:e0297790.
- JOHNSON SM, Teh JJ, Pasvol TJ, Ayres S, et al
Hospitalisation rates for youth living with perinatally acquired HIV in England.
PLoS One. 2024;19:e0295639.
- GANTA AG, Wabeto E, Minuta WM, Wegi C, et al
Predictors of loss to follow up among adults on antiretroviral therapy before and
after the start of treat-all strategy in public health facilities of Hawassa
city, Ethiopia: A Competing risk regression.
PLoS One. 2024;19:e0299505.
PLoS Pathog
- LAYISH B, Goli R, Flick H, Huang SW, et al
Virus specificity and nucleoporin requirements for MX2 activity are affected by
GTPase function and capsid-CypA interactions.
PLoS Pathog. 2024;20:e1011830.
Proc Natl Acad Sci U S A
- SHICHIJO T, Yasunaga JI, Sato K, Nosaka K, et al
Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
Proc Natl Acad Sci U S A. 2024;121:e2309925121.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016